Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My name is AF I know all truths and I can cure all your diseases. From blogger to miracles. Master of the narratives, hasn’t accomplished anything except for his media pocketbook
— Michael Bigger (@biggercapital) April 17, 2023
that's better scotty.
The talks are said to be in the late stage with a deal possibly announced as soon as Sunday, according to The Wall Street Journal.
A deal is not certain and could still fall apart.
Merck is looking to add new products to its pipeline as its top-selling drug cancer therapy Keytruda, IS EXPECTED TO LOSE PATENT PROTECTION THIS DECADE.
$NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial.https://t.co/pfRDJT4azX pic.twitter.com/bPZrGcjabh
— Henry (@HenryMuney) April 14, 2023
fair enough.
scotty. ok so lets say everything you say is true then why are you still here posting for the last 20 years? just wondering why
1 Expected to be approved for marketing-a new diagnosis of glioma DCVax-L vaccine
On May 29, 2018, Northwest Biology disclosed the phase III interim data of its personalized autologous dendritic cell vaccine DCVax-L: a personalized glioblastoma vaccine may prolong the long-term survival of some patients . The vaccine, called DCVax- L, uses the patient's own dendritic cells to help activate the immune system to fight cancer.
Nearly 30% of the patients in the trial have survived for at least three years since they were enrolled in the clinic (the patients will continue to be followed up). It is worth mentioning that this study is by far the largest clinical trial of a customized vaccine in patients diagnosed with fatal brain cancer.
Between July 2007 and November 2015, the vaccine was administered to newly diagnosed glioblastoma patients in 80 locations around the world , and all patients received standard treatment (surgical removal of the tumor, followed by surgery) before participating in the trial. Chemotherapy).
Due to the crossover design of the trial, nearly 90% of the patients received the vaccine treatment in the end.
The interim trial data of the previously announced phase III clinical study. Of the patients enrolled in the clinic for more than three years, 67 patients (30% ) survived more than 30 months, and 44 patients (24.2%) survived more than 36 months . The median survival time of these patients is estimated to be 46.5 to 88.2 months. At the time of analysis, 108 (32.6%) of the 331 patients who participated in the trial were still alive.
So far, the clinical trial of DCVax-L has been conducted for 12 years, which is extraordinary. The first patient was enrolled 12 years ago, and the last patient was enrolled 5 years ago. Everyone is looking forward to the final data of this therapy, and also looking forward to its approval as the first immunotherapy for brain tumors as soon as possible!
2 The progression-free survival is increased by 50%, and the AV-GBM-1 vaccine brings new hope to patients with brain tumors
Does The Jimmy Fund @StrikeoutCancer know that one of The Henry's companies-- Stat News--has been actively trying to destroy a proven cancer treatment for a decade? Lies so shameless that cancer sites were forced to remove. What hypocrisy. $nwbo
— annie post (@apwriter) April 13, 2023
maybe someone can forward this to here as well https://twitter.com/NBTStweets
Just some now-deleted tweets from 10 years ago from @statnews reporter @adamfeuerstein
— Varro Analytics 🇺🇸 (@Varro_Analytics) August 9, 2022
Editors @rickberke @GideonGil any comment?
Recent Twitter bio profile line: “The likes of Adam Feuerstein attack viciously” https://t.co/LSqgQVAwwS pic.twitter.com/avgHEqjGQq
Dear Harvard,
— Lisa🇺🇸🇺🇦 (@LisainNJUSA) April 12, 2023
My husband was diagnosed w/ a Grade 4 GBM brain tumor last May. Before you cut any ribbons, please do some due diligence and find out what @citsecurities, Ken's company has been doing to the company that's poised to cure this and all solid tumors. #NWBO #DCVAX pic.twitter.com/COOQ06nfUY
Hey Harvard students. One out of every four guns used in a violent crime are from companies Citadel invests in. Meanwhile it is out to destroy a tiny biotech $nwbo w a proven cancer treatment. $350mm for a building there? Where are the protests?
— annie post (@apwriter) April 12, 2023
Hey women of @bostonglobe. The Henry's are still signing this guys paycheck. Tons more just like it. Fat shaming women for years. Totally misogynist. What say you? $nwbo pic.twitter.com/XdlSEoWah3
— annie post (@apwriter) April 11, 2023
https://t.co/1aL5VjgDZg @alphavestcap Larry Smith comments on the 3/20/23 MIA MHRA approval for the Sawston, $nwbo U.K.plant https://t.co/rlJJOgy1Ej
— alphavestcapital.com (@alphavestcap) April 12, 2023
$NWBO
— Mionaer (@Mionaer1) April 8, 2023
And he is an uneducated moron….. pic.twitter.com/bTIpxdI0yJ
Wes Christian, $nwbo spoofing consultant on #citadel lawsuit, claims $nwbo squeeze will pale compared to GME or AMC given nakeds. All we need is a singular voice like @InvestorTurf to call for it. Like @Official_WSB did w GME. 11 months @ .60? Go. Pls Retweet. #CitadelScandal pic.twitter.com/432ZuuIqsr
— annie post (@apwriter) April 12, 2023
Hey @InvestorTurf I sent you this email. Like Wall Street Bets and GME we can squeeze the shit out of #citadelScandal tomorrow on your say so to followers. $nwbo .60 for 11 Months. Despite Objectively a $2 stock now. Buy $nwbo tomorrow. Please announce. We will retweet if so. https://t.co/ramDXwwvSF pic.twitter.com/dQtQG2Tren
— annie post (@apwriter) April 12, 2023
#Citadel owns a magazine. It's called @statnews. #citadelscandal $nwbo #RICO @SDNYnews @DOJCrimDiv
— annie post (@apwriter) April 12, 2023
Counsel told me if you are labeled an independent observer by a defendant you are most likely fair reach for discovery. $NWBO
— Michael Bigger (@biggercapital) April 11, 2023
@adamfeuerstein It must be awful hard to do your job when you’ve been blacklisted by JAMA. https://t.co/AWqQwUhgEJ Go #nwbo in your lawsuit against #Citadel where they specifically name @adamfeuerstein. So congratulations you’re now smack dab in it!
— gmmonson (@MysticalMagrit) April 10, 2023
JAMA. First they blacklist you. Then they sue you. @statnews lawyer up. $nwbo
— annie post (@apwriter) April 10, 2023
70 people hired for the hell of it because DCVax doesn’t work. $nwbo Perhaps you can ask your buddy why he ignored MIA news & why he thinks he is more qualified than ~70 doctors re: #GBM. This is a not an eating or making fun of women contest #fireadamfeuerstein @rickberke
— Fat Feuerstein (@fat_feuerstein) April 9, 2023
$nwbo Feuerstein continues to gaslight the DCVax-L phase 3 trial falsely claiming that the endpoint was PFS. Here are the actual facts. https://t.co/u2v1r5tooO
— Larry Smith (@SmithOnStocks1) April 9, 2023
Combining #DCVAX with other therapies should be on the forefront of next level cancer research, yet Wall St tries to bury the discovery because they bet big against the company who owns it.
— Justin Keister MS DABR (@justinkeister5) April 6, 2023
Shorts have been wrong about $NWBO at every step.
— autologous assassin 🇺🇸 🇺🇦 🇮🇱 (@flaskworks) March 31, 2023
Longs may be off on timing but the substance of the DCVax Landmark Trial Data cannot be denied by anyone that's serious. pic.twitter.com/4vNP2hKqi4
good. . 10 for us.
$NWBO injunction incoming, Ken, you ready to lie under oath again? Inc civil suits from the death of 100s of cancer patients, how can you sleep at night? @GaryGensler @adamfeuerstein
— NumbersGuy (@numbersguy91) March 31, 2023
With an injunction we'd probably mimic $cns. $.50 to $7 w squeeze. Settle around $2 unless MAA happens in between. Is @CohenMilstein trying to time it? They have all they need right now. $nwbo
— annie post (@apwriter) March 31, 2023
“Personalized…out-of-the-box, novel ways” #dcvax $nwbo https://t.co/qc2YzkuI7r
— Ida Bogac (@albtur_mnymkrs) March 31, 2023
Fireman02360
@fireman02360
·
Mar 30
It’s coming. And as I have said many times, sooner than most think $NWBO
I also recall a recent comment about something good during showers which would seem to imply April showers
Happy I think you have been here as long as I have. We can both agree who the hell knows. I will say that boxes are getting checked off and maybe that's what the train is implying.
that being said here we are still hanging around GL
or maybe the train has left